Shares of Sana Biotechnology SANA skyrocketed 151.5% in the past week after the company announced positive initial results from a potentially groundbreaking type 1 diabetes (T1D) study of its ...
Brussels SANA- Reducing energy prices in the European Union is a top priority and measures to achieve this will be revealed ...
SANA plans to dedicate the next three years to documenting and publishing the atrocities and human rights violations committed by the Baath regime over 61 years, with the aim of presenting this ...
Sana Biotechnology, Inc SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today ...
clinical and regulatory development plans and timing expectations; the ability of Sana's HIP platform to generate cells ex vivo that can evade the patient's immune system to enable the transplantation ...
The company plans to share longer follow-up data from the study in the future. Sana’s clinical pipeline comprises two other candidates, SC291 and SC262, which are being developed in separate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback